Gutfreund John Peter has filed 5 insider transactions across 1 company since April 2023.
Most recent transaction: a transaction of 3085047 shares of Insight Molecular Diagnostics Inc. ($IMDX) on June 30, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Gutfreund John Peter | Other | J | Common Stock, no par value | 3085047 | $0.00 | 3,819,372.0000 | 0 | 44.68% | 0.00% |
| June 30, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Gutfreund John Peter | Other | J | Warrants to Purchase Common Stock | 3564728 | $0.00 | 1,037,495.0000 | 0 | 77.46% | 0.00% |
| April 3, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Gutfreund John Peter | Director | A | Common Stock, no par value | 705000 | $0.35 | 1,790,000.0000 | 0 | 64.98% | 0.00% |
| April 3, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Gutfreund John Peter | Director | A | Common Stock, no par value | 1000000 | $0.35 | 1,790,000.0000 | 0 | 126.58% | 0.00% |
| April 3, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Gutfreund John Peter | Director | D | Series A Convertible Preferred Stock | 588 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |